A Review of the 2018 Asia-Pacific Working Group Consensus on Non-variceal Upper Gastrointestinal Bleeding

Joon Sung Kim and Byung-Wook Kim

doi:10.4166/kjg.2019.73.1.16

HOME > Articles >

Korean J Gastroenterol < Volume 73(1); 2019 < Articles

Korean J Gastroenterol 2019; 73(1): 16-18 https://doi.org/10.4166/kjg.2019.73.1.16

A Review of the 2018 Asia-Pacific Working Group Consensus on Non-variceal Upper Gastrointestinal Bleeding

Joon Sung Kim and Byung-Wook Kim

Division of Gastroenterology, Department of Internal Medicine, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea

Correspondence to: Byung-Wook Kim, Division of Gastroenterology, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 56 Dongsu-ro, Bupyeong-gu, Incheon 21431, Korea. Tel: +82-32-280-5052, Fax: +82-32-280-5082, E-mail: gastro@catholic.ac.kr, ORCID: https://orcid.org/0000-0002-2290-4954

Received: October 21, 2018; Revised: November 7, 2018; Accepted: November 13, 2018; Published online: January 25, 2019.

This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract: Despite recent advances in endoscopic techniques and acid-suppressive therapies, non-variceal upper gastrointestinal bleeding (NVUGIB) is still associated with significant morbidity and mortality. The increased use of dual antiplatelet agents and oral anticoagulants has complicated the management of NVUGIB. Physicians often have to decide on when to discontinue and resume these medications in patients with NVUGIB. However, clinical data regarding the resumption of antiplatelets and anticoagulants are still minimal. Here, we report and summarize the key recommendations made in the recent Asia-Pacific guidelines regarding management of antithrombotics in patients with NVUGIB.; Keywords: Non-variceal upper gastrointestinal bleeding; Guideline; Platelet aggregation inhibitors; Anticoagulants